NanoViricides, Inc.: NanoViricides Bolsters Partnership Effo

SHELTON, CT / ACCESSWIRE / May 23, 2024 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a clinical-stage global leader in broad-spectrum antiviral nanomedicines, reports that it has engaged

Related Keywords

Japan , Chicago , Illinois , United States , India , Japanese , American , , Aagami Inc , Strategic Consulting Services , Business Research Market Intelligence Services , Exchange Commission , Devices Technology , Nanoviricides Inc , Drug Administration , Securities Exchange , Committee For Medicinal Products Human , European Medicines Agency , Theracour Pharma Inc , Technology Licensing Services , Business Development , Oral Syrup , Oral Gummies , Executive Chairman , Business Research , Market Intelligence , Medical Devices , Consumer Healthcare , Deep Experience , Global Deal , Human Immunodeficiency Virus , Hepatitisb Virus , Hepatitisc Virus , Herpes Simplex Virus , Varicella Zoster Virus , Asian Bird Flu Virus , Japanese Encephalitis , West Nile Virus , Theracour Pharma , Securities Act , Securities Exchange Act , United States Securities , Good Manufacturing , Medicinal Products , Human Use , Relations Contact , Ihr Portfolio ,